Showing results (1-10 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|October 17, 2022
Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledgeAngelo Ruggiero, Matteo Megna, Gabriella Fabbrocini, et al.Expert Opinion on Drug Safety|November 5, 2022
Skin cancer signal associated with phosphodiesterase inhibitors: gaining insight through the FDA pharmacovigilance databaseJun-Wei Chow, Ming-Ming Yan, Hui Zhao, et al.Expert Opinion on Drug Safety|December 7, 2014
Do antipsychotics increase diabetes risk in children and adolescents?Britta Galling, Christoph U CorrellExpert Opinion on Drug Safety|December 23, 2014
Why are anti-obesity drugs stigmatized?Bruno Halpern, Alfredo HalpernExpert Opinion on Drug Safety|November 13, 2014
Adverse drug reactions associated with antiretroviral therapy during pregnancyMarilia Santini-Oliveira, Beatriz GrinsztejnExpert Opinion on Drug Safety|October 30, 2015
S-1-based regimens and the risk of oral and gastrointestinal mucosal injury: a meta-analysis with comparison to other fluoropyrimidinesOmar Abdel-Rahman, Hesham ElHalawani, Shaimaa Essam-EldinExpert Opinion on Drug Safety|September 3, 2015
Foetal safety of old and new antiepileptic drugsAlberto Verrotti, Elisabetta Mencaroni, Miriam Castagnino, et al.Expert Opinion on Drug Safety|June 17, 2016
A safety evaluation of belatacept for the treatment of kidney transplantValter Duro Garcia, Gisele Meinerz, Elizete KeitelExpert Opinion on Drug Safety|June 10, 2016
Tiotropium for the treatment of asthma: a drug safety evaluationHuib A M Kerstjens, Paul M O'ByrneExpert Opinion on Drug Safety|August 22, 2015
Safety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspectiveShashidhar Swamy, Meenakshi Mourya, Ganesh Kadhe, et al.Pageof 281